Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: freezing (57), icy (1), bitter (8)

Photodynamic therapy (PDT) - patient information

Description: This factsheet explains what photodynamic therapy (PDT) is and what it involves, so you know what to expect at your appointment
Url: /Media/UHS-website-2019/Patientinformation/Skin/Photodynamic-therapy-PDT-1534-PIL.pdf

Parenteral nutrition - patient information

Description: This factsheet explains what parenteral nutrition is, why you might need it and the possible risks of having it.
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Parenteral-nutrition-2707-PIL.pdf

Peripheral plasma exchange - patient information

Description: This factsheet is a guide to having plasma exchange treatment.
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Peripheral-plasma-exchange-1587-PIL.pdf

Rapid lateral flow test for COVID-19 before a procedure - patient information

Description: This factsheet provides information about taking a rapid lateral flow test for COVID-19 before your planned procedure
Url: /Media/UHS-website-2019/Patientinformation/COVID-19/Rapid-lateral-flow-test-for-COVID-19-before-a-procedure-3104-PIL.pdf

Rituximab SC (8 weekly) Ver 1

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (8 weekly) Regimen Lymphoma – Rituximab SC (8 weekly) Indication Maintenance single ag
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-8-weekly-Ver-1.pdf

Rituximab SC (12 weekly) Ver1

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (12 weekly) Regimen Lymphoma – Rituximab SC (12 weekly) Indication Maintenance single
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-12-weekly-Ver1.pdf

Rituximab (8 weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma as f
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

Rituximab (12 weekly)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB (12 weekly) Regimen Lymphoma – Rituximab (12 Weekly) Indication Non- Hodgkin’s Lymphoma a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-12-weekly.pdf

Taking oral systemic anti-cancer therapy (SACT) - patient information

Description: This factsheet gives information about taking oral systemic anti-cancer therapy (SACT).
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Taking-oral-systemic-anti-cancer-therapy-SACT-3103-PIL.pdf

Vinorelbine PO (day 1, 8, 15) Ver 1.2

Description: Chemotherapy Protocol BREAST CANCER VINORELBINE Oral (Day 1, 8, 15) Regimen Breast Cancer – Vinorelbine Oral (day 1, 8, 15) Indication Treatment of lo
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-PO-day-1-8-15-Ver-1.2.pdf

131 to 140 of 232

Previous … 12 13 14 15 16 … Next